Characterization of TGFβ-associated molecular features and drug responses in gastrointestinal adenocarcinoma

BACKGROUND: Gastrointestinal adenocarcinoma (GIAD) has caused a serious disease burden globally. Targeted therapy for the transforming growth factor beta (TGF-β) signaling pathway is becoming a reality. However, the molecular characterization of TGF-β associated signatures in GIAD requires further e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiaofeng, Liu, Furong, Qin, Lu, Liao, Zhibin, Song, Jia, Liang, Huifang, Chen, Xiaoping, Zhang, Zhanguo, Zhang, Bixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274021/
https://www.ncbi.nlm.nih.gov/pubmed/34247571
http://dx.doi.org/10.1186/s12876-021-01869-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274021/
https://www.ncbi.nlm.nih.gov/pubmed/34247571
http://dx.doi.org/10.1186/s12876-021-01869-4

Ejemplares similares